Newmont Earnings Eve: Analysts Lift Targets as Insiders Sell

NEM reports Q3 results on October 22, and the setup heading in is more interesting for what the Street is doing with its pencils than for anything happening in the borrow market.

Citigroup raised its price target on Newmont from $125 to $140 on October 20, maintaining its Buy rating, a notable move the day before the print. That lifts the Street's mean target to $136.71, roughly 17% above yesterday's close of $116.81. Barclays trimmed its target fractionally to $123 on October 19, but kept its Overweight. The broader analyst picture is constructive: RBC Capital holds a $155 target with an Outperform, and Bernstein sits at $144, also Outperform. The direction of recent target revisions is mixed rather than aligned, with Barclays cutting three times since July while others have raised, but no one has pulled a positive rating. NEM's EV/EBITDA of 6.7x and P/E of 11.8x are modest for the world's largest gold miner, and the EV/EBIT factor ranks in the 78th percentile of the universe, suggesting the multiple remains reasonable against peers even after the stock's roughly 32% year-to-date run. The dividend factor score ranks in the 93rd percentile, worth noting for income-oriented holders watching whether free cash flow from a rising gold price feeds the payout.

On the selling side, insider activity has run one way. CEO Natascha Viljoen has sold shares in three consecutive months: 7,764 shares in August, 3,882 in September, and 3,882 on October 1. CFO Brian Tabolt sold 11,445 shares on August 5 for roughly $1.2 million, a discretionary sale with no 10b5-1 plan disclosed. Net insider sales over the past 90 days come to approximately 36,000 shares worth $3.9 million. Most of the CEO and EVP sales were made under pre-arranged 10b5-1 plans, which reduces their signalling value, but Tabolt's August disposal was not covered by such a plan, which makes it the more notable of the group. The insider picture is a consistent trickle of selling at prices between $93 and $123, not a cluster of panic, but it does sit in contrast to the analyst community's generally constructive stance.

Short positioning gives little away as a standalone angle. Short interest is just 1.5% of free float, up about 2% on the week but down 7% over the past month. Borrow costs have actually eased to 0.32%, down 12% on the week, and availability is effectively uncapped, with over a billion shares available to lend. Options positioning is neutral to mildly constructive: the put/call ratio of 0.77 sits just below its 20-day average of 0.77, nearly flat, and within a tight range. There is no options-market signal of anxiety ahead of the print.

Wikipedia attention for NEM has spiked to a z-score of 2.1 against its own 90-day history, the highest retail-attention reading in recent weeks. That reflects the proximity of the earnings date and the broader gold price story, with spot approaching $4,000 per ounce, rather than anything specific in the financials. Retail interest of this kind typically clusters around major events, and with Q3 results due tomorrow afternoon, it is consistent with the calendar rather than any new information.

Among close peers, AEM dipped 0.7% on the day and is up just 0.3% on the week, while RGLD rose 1.2% on the day and 2.3% on the week. CDE is the outlier, down nearly 7% over the past week. NEM's 1.1% weekly gain sits above the median for its peer group, though the stock is still about 5% below its one-month-ago level. The share's recent softness, despite gold near record highs, is the tension the October 22 print will need to address, and whether operating costs and production volumes from the reshaped post-Newcrest portfolio have kept pace with the commodity tailwind.